Penna P - Search Results

1

Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.

Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, Orlewska E, Penna P, Rodriguez Barrios JM, Shau WY. Sullivan SD, et al. Among authors: penna p. Value Health. 2014 Jan-Feb;17(1):5-14. doi: 10.1016/j.jval.2013.08.2291. Epub 2013 Dec 13. Value Health. 2014. PMID: 24438712 Free article.

2

Fixed-Dose Combination Gel of Adapalene and Benzoyl Peroxide plus Doxycycline 100 mg versus Oral Isotretinoin for the Treatment of Severe Acne: Efficacy and Cost Analysis.

Penna P, Meckfessel MH, Preston N. Penna P, et al. Am Health Drug Benefits. 2014 Jan;7(1):37-45. Am Health Drug Benefits. 2014. PMID: 24991389 Free PMC article.

3

Successful implementation of a guideline program for the rational use of lipid-lowering drugs.

Stuart ME, Handley MA, Chamberlain MA, Wallach RW, Penna PM, Stergachis A. Stuart ME, et al. Among authors: penna pm. HMO Pract. 1991 Nov-Dec;5(6):198-204. HMO Pract. 1991. PMID: 10115851

4

Clinical pharmacy and managed health care systems: considerations for program development and evaluation.

Stergachis A, Campbell WH, Penna PM. Stergachis A, et al. Among authors: penna pm. Top Hosp Pharm Manage. 1988 Nov;8(3):78-88. Top Hosp Pharm Manage. 1988. PMID: 10314317 No abstract available.

5

Effect of clinical pharmacists on drug prescribing in a primary-care clinic.

Stergachis A, Fors M, Wagner EH, Sims DD, Penna P. Stergachis A, et al. Among authors: penna p. Am J Hosp Pharm. 1987 Mar;44(3):525-9. Am J Hosp Pharm. 1987. PMID: 3565410 Clinical Trial.

6

Nonsteroidal antiinflammatory drug discontinuation in patients with osteoarthritis.

Scholes D, Stergachis A, Penna PM, Normand EH, Hansten PD. Scholes D, et al. Among authors: penna pm. J Rheumatol. 1995 Apr;22(4):708-12. J Rheumatol. 1995. PMID: 7791168 Clinical Trial.

7

Managed care and the community pharmacist.

Penna PM. Penna PM. Am Pharm. 1995 Jun;NS35(6):54-61; quiz 61-2. doi: 10.1016/s0160-3450(15)30119-7. Am Pharm. 1995. PMID: 7661097 No abstract available.

8

Pharmacy factors that influence the success of integrated health care systems.

Penna PM. Penna PM. Am J Health Syst Pharm. 1996 Feb 15;53(4 Suppl 1):S7-10. doi: 10.1093/ajhp/53.4_suppl_1.S7. Am J Health Syst Pharm. 1996. PMID: 8673680 No abstract available.

9

HMOs: challenges & opportunities.

Krigstein DJ, Brusadin RA, Crook DM, Naber P, Neels J, Penna PM. Krigstein DJ, et al. Among authors: penna pm. Am Pharm. 1985 Oct;NS25(10):31-9. Am Pharm. 1985. PMID: 4061278 No abstract available.

10

Point/counterpoint. The HMO pharmacy benefit. In-house pharmacy administration: the benefits of integration.

Penna P. Penna P. HMO. 1995 Jul-Aug;36(4):56, 58-9. HMO. 1995. PMID: 10166487 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page